reunited with family, and new details of life in hamas captivity. a 9-year-old boy and his family living in fear, moved constantly between tunnels and apartments. our interview tonight. also tonight, the suspect in court charged with shooting three palestinian college students in vermont. our exclusive interview with the family of one victim in the west bank. their fears he will never walk again. the fbi investigation. was it a hate crime? the new escalation. ballistic missiles fired near a u.s. warship in the middle east. what the pentagon is saying. the lake effect snowstorm impacting the midwest and northeast. al roker is tracking it for us. and cyber monday is here. the best deals. and will this year shatter records? the memorials under way to rosalynn carter. will her husband, former president jimmy carter, be able to leave hospice to attend? announcer: this is nbc nightly news with lester holt. good evening. there is joy tonight inside and outside isra
Cambridge: AstraZeneca and Sanofi s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by.
The government-funded programs have been designed to ensure infants and young children at the highest risk of severe disease from RSV are protected at the right time.
There is a critical shortage of the RSV vaccine for children leaving pediatricians in a struggle to give the shots and parents worried about the health of their child.
There is a new shot to protect newborns against RSV, but parents may not be able to get it or afford it. There is a lack of supply and it costs too much, an average of $500 without insurance.